Testing in pharmaceutical quality control is a critical process for ensuring quality, and the water quality and management of the water used are of utmost importance. The testing methods for pharmaceuticals are stipulated in the Japanese Pharmacopoeia, and the current Japanese Pharmacopoeia sets specifications for water used in pharmaceutical testing in its general notices, general tests, and reference information. In 2026, the Japanese Pharmacopoeia is scheduled to be revised. This webinar will cover not only the latest revisions to the Japanese Pharmacopoeia, but also the water quality and purification methods for water used in testing, as well as the water quality, production, and management methods suitable for each type of test.
Date: Wednesday, June 17, 2026 | 15:00 – 16:00
Free / Online
(Opens an external site)
Registration due date
Registration deadline: 14:00 on the day of the event.
Program
≪Main Topics≫
- Specifications for water for testing in the 19th Edition of the Japanese Pharmacopoeia, scheduled for revision in 2026
- Impact of water quality on various tests
- Purification and management methods for water suitable for testing
Speakers
Keita Yagi
Merck Ltd. (Japan), Life Science Lab Water Business Division, Marketing
Target
Those involved in pharmaceutical-related testing and quality control operations.
Participation Fee
Free / Online
Capacity
500 participants — Pre-registration is required to attend.
Organizer
Hosted by: Merck Ltd.
Contact
For inquiries regarding the schedule and registration, please contact jpmcom@merckgroup.com.